Article
Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Journal for immunotherapy of cancer - 1 Jan 2022
Yang Lei, He Yun-Ting, Dong Song, Wei Xue-Wu, Chen Zhi-Hong, Zhang Bo, Chen Wei-Dong, Yang Xiao-Rong, Wang Fen, Shang Xue-Meng, Zhong Wen-Zhao, Wu Yi-Long, Zhou Qing
Abstract excerpt
BACKGROUNDS: Immunotherapy is less effective in patients with epidermal growth factor receptor (EGFR) mutant non-small-cell lung cancer (NSCLC). Lower programmed cell death-ligand 1 (PD-L1) expression and tumor mutation burden (TMB) are reported to be the underlying mechanism. Being another important factor to affect the efficacy of immunotherapy, tumor microenvironment (TME) characteristics of this subgroup of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
